Sickle Cell Disease study: Cogmed+
Official title Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
ClinicalTrials.gov ID: NCT06770010
What this study is testing
- What it's testing
- The study wants to see if the program is doable, liked, and helpful for improving memory training adherence in these children.
- Who it's for
- Children aged 7 to 16 with sickle cell disease.
- What's involved
- Participants will use a computer‑based memory training program, receive social support, and learn memory strategies, with regular check‑ins and tests.
- Time commitment
- The trial lasts several weeks, with scheduled visits and online training sessions throughout the study period.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 16
You may be able to join if
- Diagnosis of sickle cell disease (any genotype).
- Between ages 7-16 years old.
- Patients will only enter the treatment phase if they score \>1 SD below the normative mean on at least one standardized working memory assessment...
You likely can't join if
- Motor, visual, or auditory impairment that prevents computer use.
- Diagnosis of a mental health condition that precludes, or takes treatment precedence over, participation in the cognitive training.
- History of photosensitive seizures.
- Insufficient English fluency.
- Recent initiation or dose adjustment of a stimulant medication to treat attention problems (\< 30 days).
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.